======= PI4KA =======
== Gene Information ==
* **Official Symbol**: PI4KA
* **Official Name**: phosphatidylinositol 4-kinase alpha
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5297|5297]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P42356|P42356]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PI4KA&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PI4KA|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600286|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. [provided by RefSeq, Sep 2014].
* **UniProt Summary**: Acts on phosphatidylinositol (PtdIns) in the first committed step in the production of the second messenger inositol- 1,4,5,-trisphosphate. {ECO:0000269|PubMed:10101268, ECO:0000269|PubMed:23229899}.
|PI3Ka|
|PI3 PI4 kinase|
|viral replication complex formation and maintenance|
|viral replication complex|
|1-phosphatidylinositol 4-kinase activity|
|multi-organism membrane organization|
|viral RNA genome replication|
|Golgi-associated vesicle membrane|
|multi-organism cellular process|
|viral genome replication|
|phosphatidylinositol phosphorylation|
|lipid phosphorylation|
|phosphatidylinositol-mediated signaling|
|inositol lipid-mediated signaling|
|kinase activity|
|phosphatidylinositol biosynthetic process|
|phosphatidylinositol metabolic process|
|viral life cycle|
|lipid modification|
|glycerophospholipid biosynthetic process|
|glycerolipid biosynthetic process|
|phospholipid biosynthetic process|
|glycerophospholipid metabolic process|
|cadherin binding|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|focal adhesion|
|organophosphate biosynthetic process|
|lipid biosynthetic process|
|viral process|
|symbiotic process|
|interspecies interaction between organisms|
|membrane organization|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|lipid metabolic process|
|phosphorylation|
|ATP binding|
|intracellular signal transduction|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-1.87|
|[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.72|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.71|
|[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.91|
|[[:results:exp475|CyclicAMP 200μM R08 exp475]]|1.96|
|[[:results:exp107|UMK57 0.6μM R03 exp107]]|2.13|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 464/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|0/1|
|bile duct|16/28|
|blood|11/28|
|bone|16/26|
|breast|25/33|
|central nervous system|34/56|
|cervix|3/4|
|colorectal|13/17|
|esophagus|7/13|
|fibroblast|1/1|
|gastric|15/16|
|kidney|11/21|
|liver|11/20|
|lung|51/75|
|lymphocyte|11/16|
|ovary|22/26|
|pancreas|17/24|
|peripheral nervous system|6/16|
|plasma cell|8/15|
|prostate|0/1|
|skin|11/24|
|soft tissue|6/9|
|thyroid|1/2|
|upper aerodigestive|11/22|
|urinary tract|23/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1138
* **Expression level (log2 read counts)**: 8.08
{{:chemogenomics:nalm6 dist.png?nolink |}}